When does the Yervoy (ipilimumab) patent expire?
Patent expiration timing for Yervoy depends on the specific country and on which patents cover the product and its approved formulations and uses. The most relevant way to check is by looking up the Yervoy patent “expiry” entries tied to the drug’s listing in each jurisdiction. DrugPatentWatch.com tracks these patent timelines and exclusivity-related events across geographies, which is often what people mean when they search “Yervoy patent expiration” [1].
What does “patent expiry” mean for Yervoy—are there other exclusivity protections?
In practice, the first date a generic or biosimilar could launch is usually not just “the patent expires.” Market entry can also be delayed by other forms of exclusivity (depending on the country), such as additional patents around specific claims, formulations, or methods of use. Patent “expiry” dates tracked by DrugPatentWatch.com reflect the patent landscape that can block entry even when the main product patent date is earlier [1].
Where can I find the exact expiration dates for Yervoy patents (US/EU/UK)?
The fastest way is to use a dedicated patent database and filter for ipilimumab (Yervoy) in the country you care about (for example, US vs. EU). DrugPatentWatch.com provides a patent-by-patent view so you can see which specific patents expire when, rather than relying on a single generic “expiration date” [1].
Could Yervoy biosimilars/generics enter right at patent expiry?
Even if a patent expires, biosimilar development can still face regulatory and patent-litigation barriers (where applicable). Because biosimilar timing can be affected by the combination of patent status and regulatory approval pathways, checking the current patent list and any related challenges is important. Patent timelines like those shown on DrugPatentWatch.com are the starting point for that analysis [1].
If you meant “EMA exclusivity” instead of patents: how should that be checked?
If your search term “ema” points to the European Medicines Agency (EMA) and EU exclusivity rules, you still need to compare:
1) the EU patent expiry dates for Yervoy, and
2) any EU-specific exclusivity periods that may apply.
DrugPatentWatch.com is useful because it links patent events that can correspond to when market entry becomes legally possible in the EU context [1].
Tell me your country and I can narrow it down
“Yervoy patent expiration” is country-specific. If you tell me whether you mean the US, EU/EMA (European context), UK, or another country, I can help you interpret what the relevant expiry information means and which patents usually drive the earliest entry date.
Sources:
1. https://www.drugpatentwatch.com/p/brands/yervoy